Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Nicoletti

Showing results (491-500 of 548) with videos related to

Pageof 55
Sort By:
International Journal of Molecular Sciences|February 13, 2025
Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum LevelsGiada Trovini, Ginevra Lombardozzi, Georgios D Kotzalidis, et al.
Human Psychopharmacology|February 9, 2021
Inverse correlation between plasma 2-arachidonoylglycerol levels and subjective severity of depressionGiuseppe Bersani, Francesca Pacitti, Angela Iannitelli, et al.
Epilepsia|September 16, 2017
Alterations in the α<sub>2</sub> δ ligand, thrombospondin-1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsiesInes Santolini, Roberta Celli, Milena Cannella, et al.
Molecular Cancer Therapeutics|May 7, 2009
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of AktDanijela Maksimovic-Ivanic, Sanja Mijatovic, Djordje Miljkovic, et al.
Pharmacology Research & Perspectives|July 15, 2015
Antidepressant activity of fingolimod in miceLuigi di Nuzzo, Rosamaria Orlando, Cristina Tognoli, et al.
Neuromolecular Medicine|July 30, 2013
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosisFrancesco Mori, Robert Nisticò, Georgia Mandolesi, et al.
Current Neuropharmacology|May 17, 2022
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics DataRoberta Celli, Pasquale Striano, Rita Citraro, et al.
Nitric Oxide : Biology and Chemistry|May 8, 2008
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cellsSanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
Expert Opinion on Emerging Drugs|February 16, 2010
Emerging MEK inhibitorsJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Pharmacological Research|February 14, 2018
Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological targetFilippo Caraci, Simona Federica Spampinato, Maria Grazia Morgese, et al.
Pageof 55

Showing results (491-500 of 548) with videos related to

Sort By:
Pageof 55
International Journal of Molecular Sciences|February 13, 2025
Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum LevelsGiada Trovini, Ginevra Lombardozzi, Georgios D Kotzalidis, et al.
Human Psychopharmacology|February 9, 2021
Inverse correlation between plasma 2-arachidonoylglycerol levels and subjective severity of depressionGiuseppe Bersani, Francesca Pacitti, Angela Iannitelli, et al.
Epilepsia|September 16, 2017
Alterations in the α<sub>2</sub> δ ligand, thrombospondin-1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsiesInes Santolini, Roberta Celli, Milena Cannella, et al.
Molecular Cancer Therapeutics|May 7, 2009
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of AktDanijela Maksimovic-Ivanic, Sanja Mijatovic, Djordje Miljkovic, et al.
Pharmacology Research & Perspectives|July 15, 2015
Antidepressant activity of fingolimod in miceLuigi di Nuzzo, Rosamaria Orlando, Cristina Tognoli, et al.
Neuromolecular Medicine|July 30, 2013
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosisFrancesco Mori, Robert Nisticò, Georgia Mandolesi, et al.
Current Neuropharmacology|May 17, 2022
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics DataRoberta Celli, Pasquale Striano, Rita Citraro, et al.
Nitric Oxide : Biology and Chemistry|May 8, 2008
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cellsSanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
Expert Opinion on Emerging Drugs|February 16, 2010
Emerging MEK inhibitorsJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Pharmacological Research|February 14, 2018
Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological targetFilippo Caraci, Simona Federica Spampinato, Maria Grazia Morgese, et al.
Pageof 55